<SEC-DOCUMENT>0001104659-23-004380-index.html : 20230117
<SEC-HEADER>0001104659-23-004380.hdr.sgml : 20230117
<ACCEPTANCE-DATETIME>20230117211624
ACCESSION NUMBER:		0001104659-23-004380
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20230117
FILED AS OF DATE:		20230117
DATE AS OF CHANGE:		20230117

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Norry Elliot
		CENTRAL INDEX KEY:			0001798117

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37368
		FILM NUMBER:		23532759

	MAIL ADDRESS:	
		STREET 1:		C/O ADAPTIMMUNE THERAPEUTICS PLC
		STREET 2:		60 JUBILEE AVE, MILTON PARK
		CITY:			ABINGDON, OXFORDSHIRE
		STATE:			X0
		ZIP:			OX14 4RX

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adaptimmune Therapeutics PLC
		CENTRAL INDEX KEY:			0001621227
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		60 JUBILEE AVENUE
		STREET 2:		MILTON PARK
		CITY:			ABINGDON, OXFORDSHIRE
		STATE:			X0
		ZIP:			OX14 4RX
		BUSINESS PHONE:		44 1235 430000

	MAIL ADDRESS:	
		STREET 1:		60 JUBILEE AVENUE
		STREET 2:		MILTON PARK
		CITY:			ABINGDON, OXFORDSHIRE
		STATE:			X0
		ZIP:			OX14 4RX

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Adaptimmune Ltd
		DATE OF NAME CHANGE:	20141001
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>tm231655-18_4seq1.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
Document 1 - file: tm231655-18_4seq1.html

Document 1 - RAW XML: tm231655-18_4seq1.xml

</DOCUMENT>
</SEC-DOCUMENT>